Hainan University has unveiled its proprietary core technology and product line for implantable brain-computer interfaces (BCIs), comprising state-of-the-art dedicated chips, neural signal acquisition, modulation, and localization systems. This milestone signifies the achievement of full-chain technological autonomy and control, with performance matching the highest international standards, thereby ending import dependency. This announcement has sparked a rally in A-share stocks related to the brain-computer interface sector, with notable gains seen in companies like Innovative Medical and Yanshan Technology.
